Middlemen, not drug companies, are pushing up insulin prices, and Congress doesn’t have the right plan to fight back

Why should those who distribute insulin, such as pharmacy-benefit managers, get more than half of the money spent by consumers?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.